Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and -042 trials
Roy S. Herbst, G. Lopes, D.M. Kowalski et al. · Annals of Oncology · 2019
Cited by 101 works. doi:10.1093/annonc/mdz394.077